Condition: Hemolytic Disease of the Fetus and Newborn · Sponsor: Janssen Research & Development, LLC
The purpose of this non-interventional study is to prospectively evaluate the risk of anemia (decreased red blood cells) in fetuses (baby before birth) and neonates (baby just after birth) of pregnant participants who are at risk for hemolytic disease of the fetus and newborn (HDFN) and receiving standard of care (SoC). HDFN is a blood disease that occurs in babies before birth or just after birth when the blood types of the pregnant individual and babies are incompatible, thus resulting in fast breakdown of red blood cells (RBCs) of the fetus/baby.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| Riley Children s Hospital | Indianapolis, Indiana, United States | Recruiting |
| University of Cincinnati | Cincinnati, Ohio, United States | Recruiting |
| Oregon Health And Science University | Portland, Oregon, United States | Recruiting |
| Baylor College of Medicine | Houston, Texas, United States | Recruiting |
| The Royal Women's Hospital | Parkville, Australia | Recruiting |
| Mater Misericordiae Ltd | South Brisbane, Australia | Recruiting |
| Universitair Ziekenhuis Gent | Ghent, Belgium | Recruiting |
| Universitair Ziekenhuis Leuven | Leuven, Belgium | Recruiting |
| State University of Campinas Joao Bennini | Campinas, Brazil | Recruiting |
| Interdiszip Schwerpunkt fur Hamostaseologie | Giessen, Germany | Recruiting |
| Mangiagalli Clinic IRCCS Ca Granda Foundation Ospedale Maggiore Policlinico | Milan, Italy | Recruiting |
| Fondazione Policlinico Universitario A Gemelli IRCCS | Roma, Italy | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07194070